Clinical outcomes and emergency healthcare utilization in patients with severe asthma who continued, switched or stopped biologic therapy: results from the CLEAR study

Nasloon Ali, Stephanie Chen, Trung N Tran, Bill Cook, Alan Altraja, Arnaud Bourdin, Chau-Chyun Sheu, Ming-Ju Tsai, Flavia C L Hoyte, Anna Quinton, Benjamin Emmanuel, Celine Y.Y. Goh, Victoria Carter, David Price

Research output: Contribution to journalAbstractpeer-review

2 Downloads (Pure)


Original languageEnglish
Pages (from-to)A23-A27
Issue number4, Supplement
Early online date31 Oct 2022
Publication statusPublished - Oct 2022
EventCHEST Annual Meeting - Nashville, United States
Duration: 16 Oct 202219 Oct 2022

Bibliographical note

This study was funded by AstraZeneca. The International Severe Asthma Registry is jointly funded by Optimum Patient Care Global and AstraZeneca.
Medical writing support was provided by Madeleine Wynn, MRes, of PharmaGenesis
London, London, UK, with funding from AstraZeneca.

Cite this